Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-25-061044
Filing Date
2025-04-30
Accepted
2025-04-30 16:08:32
Documents
16
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A rkda-20241231.htm   iXBRL 10-K/A 1711560
2 EX-19.1 rkda-ex19_1.htm EX-19.1 110568
3 EX-31.1 rkda-ex31_1.htm EX-31.1 9467
4 EX-31.2 rkda-ex31_2.htm EX-31.2 9438
  Complete submission text file 0000950170-25-061044.txt   2272403

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rkda-20241231.xsd EX-101.SCH 53209
18 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20241231_htm.xml XML 16307
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37383 | Film No.: 25895074
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)